Clinical Trial: Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199218) titled 'Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism' on Sept. 11.

Brief Summary: The goal of this clinical trial is to determine whether cannabidiol (CBD, 28%) combined with terpenes and a small amount of THC (1%) can help reduce symptoms of autism, and to evaluate the safety of this treatment.

The main questions are:

1. Does this treatment improve behavioral challenges in children with autism?

2. Does this treatment improve social difficulties in children with autism?

What will happen in the study:

1. Participants take either the study treatment or a placebo (a look-alike substance with no...